January 10, 2015 Global Collaboration to Develop New and Existing Drugs for Neonates Davis JM, Turner MA. Global Collaboration to Develop New and Existing Drugs for Neonates. JAMA pediatrics. 2015 Oct;169(10):887–
January 10, 2015 A Collaborative Approach for “ReSeq-Ing” Mycobacterium Tuberculosis Drug Resistance: Convergence for Drug and Diagnostic Developers
January 6, 2015 Critical Path Institute Secures Regulatory Support For Autosomal Dominant Polycystic Kidney Disease (ADPKD) Biomarker June 1, 2015 Critical Path Institute Secures Regulatory Support For Autosomal Dominant Polycystic Kidney Disease (ADPKD) Biomarke
January 6, 2015 Patient-Reported Outcomes In Cancer Drug Development And US Regulatory Review: Perspectives From Industry, The Food And Drug Administration, And The Patient
January 4, 2015 Target Product Profile of a Molecular Drug-Susceptibility Test for Use in Microscopy Centers
January 4, 2015 Integration of Published Information into a Resistance-Associated Mutation Database for Mycobacterium Tuberculosis
January 3, 2015 Alzheimer’s and Parkinson’s Diseases Face Common Challenges in Therapeutic Development: Role of the Precompetitive Consortium, Coalition Against Major Diseases
